Ratio Analysis: Unpacking Humana Inc (HUM)’s Price-to-Cash and Price-to-Free Cash Flow

Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.

After finishing at $284.82 in the prior trading day, Humana Inc (NYSE: HUM) closed at $286.78, up 0.69%. In other words, the price has increased by $0.69 from its previous closing price. On the day, 1.15 million shares were traded. HUM stock price reached its highest trading level at $288.42 during the session, while it also had its lowest trading level at $280.31.

Ratios:

Our goal is to gain a better understanding of HUM by taking a closer look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.70.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on November 06, 2024, Upgraded its rating to Neutral and sets its target price to $308 from $247 previously.

Bernstein Upgraded its Mkt Perform to Outperform on October 08, 2024, while the target price for the stock was maintained at $308.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 08 ’25 when Diamond Susan M bought 10,959 shares for $249.31 per share.

Huval Timothy S. bought 1,247 shares of HUM for $322,443 on Feb 24 ’25. On Dec 31 ’24, another insider, Huval Timothy S., who serves as the Chief Administrative Officer of the company, sold 3,703 shares for $256.26 each. As a result, the insider received 948,925 and left with 8,181 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HUM now has a Market Capitalization of 34612338688 and an Enterprise Value of 26879498240. As of this moment, Humana’s Price-to-Earnings (P/E) ratio for their current fiscal year is 28.80, and their Forward P/E ratio for the next fiscal year is 20.13. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.72. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.29 while its Price-to-Book (P/B) ratio in mrq is 2.11. Its current Enterprise Value per Revenue stands at 0.228 whereas that against EBITDA is 8.021.

Stock Price History:

The Beta on a monthly basis for HUM is 0.46, which has changed by -0.11339885 over the last 52 weeks, in comparison to a change of 0.07455289 over the same period for the S&P500. Over the past 52 weeks, HUM has reached a high of $406.46, while it has fallen to a 52-week low of $213.31. The 50-Day Moving Average of the stock is 7.58%, while the 200-Day Moving Average is calculated to be -3.73%.

Shares Statistics:

The stock has traded on average 1.70M shares per day over the past 3-months and 2106220 shares per day over the last 10 days, according to various share statistics. A total of 120.64M shares are outstanding, with a floating share count of 120.43M. Insiders hold about 0.22% of the company’s shares, while institutions hold 97.10% stake in the company. Shares short for HUM as of 1743379200 were 3660873 with a Short Ratio of 2.16, compared to 1740700800 on 3660419. Therefore, it implies a Short% of Shares Outstanding of 3660873 and a Short% of Float of 3.4000000000000004.

Dividends & Splits

In the trailing 12 months, HUM’s forward annual dividend rate was 3.54, compared to 3.54 this year. Against a Trailing Annual Dividend Yield of 0.012428902The stock’s 5-year Average Dividend Yield is 0.76. The current Payout Ratio is 35.45% for HUM, which recently paid a dividend on 2025-03-28 with an ex-dividend date of 1743120000. Stock splits for the company last occurred on 1991-08-01 when the company split stock in a 3:2 ratio.

Most Popular